• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

CC-115 hydrochloride

CAS No. 1300118-55-1

CC-115 hydrochloride ( —— )

产品货号. M11206 CAS No. 1300118-55-1

一种新型 mTOR 和 DNA-PK 双重抑制剂,IC50 分别为 21 nM 和 13 nM。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
500MG ¥13422 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    CC-115 hydrochloride
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    一种新型 mTOR 和 DNA-PK 双重抑制剂,IC50 分别为 21 nM 和 13 nM。
  • 产品描述
    A novel dual inhibitor of mTOR and DNA-PK with IC50 of 21 nM and 13 nM, respectively; blocks both mTORC1(pS6) and mTORC2(pAktS473) signaling in PC-3 cancer cells, in vitro and in vivo; exhibits dose-dependent efficacy in tumor xenograft models.Blood Cancer Phase 1 Clinical.
  • 体外实验
    CC-115 inhibits PC-3 cells proliferation with an IC50 of 138 nM. In a kinase selectivity assessment against a panel of 250 protein kinases at 3 μM, only one kinase other than mTOR kinase is identified with more than 50% inhibition (cFMS 57%, IC50=2.0 μM). Of the PI3K related kinases (PIKKs) tested, CC-115 proves to be equipotent against DNA PK (IC50=15 nM) and demonstrates 40 to >1000 fold selectivity against the remaining PIKKs tested; PI3K-alpha (IC50=0.85 μM), ATR (50% inhibition at 30 μM) and ATM (IC50>30 μM). The IC50 values for CC-115 are >10 μM against a panel of CYP enzymes and >33 μM for the hERG (human ether-a-go-go-related gene) ion channel. When screened in a single point assay at 10 μM against a Cerep receptor and enzyme panel only one target is inhibited >50% (PDE3, IC50=0.63 μM).
  • 体内实验
    CC-115 hydrochloride shows good in vivo PK profiles across multiple species with 53%, 76% and ~100% oral bioavailability in mouse, rat and dog, respectively. CC-115 is tested at lower doses of 0.25, 0.5 and 1 mg/kg bid or 1 mg/kg qd, with observed corresponding tumor volume reductions of 46%, 57%, 66% and 57% respectively. CC-115 sustains inhibition though 24 hours. At the 1 mg/kg dose CC-115 shows significant inhibition at 1 and 3 hours, CC-115 demonstrating inhibition through 10 hours. CC-115 is evaluated using both once (qd) and twice (bid) daily dosing schedules.
  • 同义词
    ——
  • 通路
    PI3K/Akt/mTOR signaling
  • 靶点
    mTOR
  • 受体
    mTOR
  • 研究领域
    Cancer
  • 适应症
    Blood cancer

化学信息

  • CAS Number
    1300118-55-1
  • 分子量
    372.8122
  • 分子式
    C16H17ClN8O
  • 纯度
    >98% (HPLC)
  • 溶解度
    DMSO: ≥ 30 mg/mL
  • SMILES
    CCN1C(=O)CNC2=NC=C(N=C21)C3=C(N=C(C=C3)C4=NC=NN4)C.Cl
  • 化学全称
    Pyrazino[2,3-b]pyrazin-2(1H)-one, 1-ethyl-3,4-dihydro-7-[2-methyl-6-(1H-1,2,4-triazol-5-yl)-3-pyridinyl]-, hydrochloride (1:x)

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Mortensen DS, et al. J Med Chem. 2015 Jul 23;58(14):5599-608. 2. Thijssen R, et al. Blood. 2016 Jul 28;128(4):574-83.
产品手册
关联产品
  • MTI-31

    MTI-31(LXI-15029,mTOR 抑制剂-31)是一种新型有效的选择性 mTORC1/mTORC2 抑制剂,Kd 为 0.2 nM (mTOR)。

  • NV-128

    NV-128 (LY-303511) 是一种新型异黄酮衍生物,可抑制 mTOR 并促进不依赖 caspase 的细胞死亡。

  • PI3Kα/mTOR-IN-1

    PI3Kα/mTOR-IN-1 是一种有效的 PI3Kα/mTOR 双重抑制剂,在细胞实验中对 PI3Kα 的 IC50 值为 7 nM,在体外酶实验中对 mTOR 和 PI3Kα 的 Ki 值分别为 10.6 nM 和 12.5 nM。